Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Teva Received FDA Approval for Tasimelteon

FDA
News

Teva Received FDA Approval for Tasimelteon

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601

byCharles Gross

December 13, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601

Why Nvidia Stock Is Surging After Hours

By Adam Eckert

October 26, 5:57 PM

NVIDIA Corp (NASDAQ: NVDA) shares are trading higher in Wednesday's after-hours session after Meta Platforms Inc (NASDAQ: META)

Alaunos Therapeutics Highlights Strategic Priorities And Anticipated Portfolio Milestones For 2023; Alaunos Ended Q4 2022 With Unaudited Cash And Cash Equivalents Of ~$39.1M And Restricted Cash Of ~$13.9M

By Benzinga Newsdesk

January 9, 9:58 AM

Announcing addition of two new TCRs to the library, estimated to double the addressable market; plans to further expand TCR library using hunTR® TCR discovery platform Increasing patient enrollment to

TCRT

Cloudflare Analysts Cut Their Forecasts After Q1 Results

By Avi Kapoor

May 3, 9:35 AM

Cloudflare, Inc. (NYSE:NET) reported upbeat earnings for its first quarter and issued FY24 revenue guidance below estimates on…

NET

Why StarTek Shares Are Trading Higher Today?

By Anusuya Lahiri

August 9, 11:28 AM

CSP Management Ltd and affiliates sent a non-binding proposal to StarTek, Inc (NYSE:SRT) to acquire all the shares of Startek that CSP…

SRT

Teva Received FDA Approval for Tasimelteon

Related Posts

Why Nvidia Stock Is Surging After Hours

Alaunos Therapeutics Highlights Strategic Priorities And Anticipated Portfolio Milestones For 2023; Alaunos Ended Q4 2022 With Unaudited Cash And Cash Equivalents Of ~$39.1M And Restricted Cash Of ~$13.9M

Cloudflare Analysts Cut Their Forecasts After Q1 Results

Why StarTek Shares Are Trading Higher Today?